Lexicon Pharmaceuticals LXRX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's earnings yield?
- Lexicon Pharmaceuticals (LXRX) reported earnings yield of -3.9% in Q1 2026.
- How has Lexicon Pharmaceuticals's earnings yield changed year-over-year?
- Lexicon Pharmaceuticals's earnings yield increased by 96.3% year-over-year, from -106.4% to -3.9%.
- What is the long-term trend for Lexicon Pharmaceuticals's earnings yield?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's earnings yield has grown at a 0.9% compound annual growth rate (CAGR), from -11.5% to -12%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.